Related Experiment Video
Updated: May 31, 2026

Procedures for In Vitro Cultivation of Treponema pallidum, the Syphilis Spirochete
Published on: January 24, 2025
Congenital syphilis in neonates: Persistent diagnostic and treatment challenges in resource-limited settings
Anjali Joshi1, Jeetinder Joshi2, Pothapregada Sriram3
1Senior Resident, Department of Neonatology, AIIMS Bilaspur, Bilaspur, Himachal Pradesh, India.
Insights
Congenital syphilis (CS) persists in low- and middle-income countries due to failures in antenatal screening and treatment. This study highlights recurring issues in preventing CS, emphasizing the need for improved interventions.
Area of Science:
- Public Health
- Infectious Diseases
- Neonatal Care
Background:
- Congenital syphilis (CS) remains a significant global health challenge, particularly in low- and middle-income countries (LMICs).
- Existing guidelines for CS prevention are often not fully implemented, leading to persistent transmission and delayed diagnoses.
- Previous reports from India have highlighted symptomatic infants with delayed diagnoses due to inadequate antenatal screening.
Purpose of the Study:
- To prospectively identify and characterize neonates born to mothers with reactive syphilis serology in northern India.
- To evaluate the effectiveness of antenatal screening and maternal treatment in preventing congenital syphilis.
- To map failures in the congenital syphilis prevention cascade in a tertiary care setting.
Main Methods:
- Prospective identification of five neonates born to mothers with reactive syphilis serology at a tertiary care center in northern India (September 2024-January 2026).
- Assessment of maternal syphilis treatment adequacy.
- Neonatal RPR testing and classification of CS probability based on CDC criteria.
- Evaluation of treatment challenges, including penicillin availability.
Main Results:
- All five neonates were asymptomatic at birth, despite reactive maternal serology.
- Adequate maternal treatment was confirmed in only two of the five cases.
- Only one neonate had a reactive neonatal RPR test.
- Based on CDC criteria, one neonate was highly probable CS, three were possible CS, and one was less likely CS.
- Limited availability of aqueous crystalline penicillin led to the use of benzathine penicillin for all infants.
Conclusions:
- Failures in the congenital syphilis prevention cascade, including antenatal screening and adequate maternal treatment, continue to impact LMICs.
- Even asymptomatic neonates born to mothers with reactive syphilis require careful evaluation and management.
- Challenges in penicillin availability and adherence to treatment protocols complicate CS management in resource-limited settings.
- Systemic improvements are needed to address recurring failures in preventing congenital syphilis.
Abstract:
Despite available guidelines, congenital syphilis (CS) continues to burden low- and middle-income countries (LMICs), with failures occurring across multiple points. Two prior case reports from India described symptomatic infants with delayed diagnoses resulting from absent or ignored antenatal screening. We add five neonates identified prospectively at birth at a tertiary care centre in northern India (September 2024-January 2026), born to mothers with reactive syphilis serology. All were asymptomatic, but maternal treatment was adequate in only two cases. Neonatal RPR was reactive in one infant only. Based on CDC criteria, one neonate was classified as highly probable CS, three as possible, and one as less likely. Limited availability of aqueous crystalline penicillin necessitated benzathine penicillin use in all cases, and one infant left against medical advice. Together, these series map recurring, correctable failures across the entire CS prevention cascade in LMICs.
Related Concept Videos
Sexually Transmitted Infections
Cryptococcal Meningitis
Trichomoniasis
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Pharmacokinetics in Pediatric Patients: Drug Excretion
